| Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy A Feldmann, A Hoffmann, R Bergmann, S Koristka, N Berndt, C Arndt, ... Oncoimmunology 9 (1), 1785608, 2020 | 46 | 2020 |
| Targeting acute myeloid leukemia using the RevCAR platform: a programmable, switchable and combinatorial strategy E Kittel-Boselli, KEG Soto, LR Loureiro, A Hoffmann, R Bergmann, ... Cancers 13 (19), 4785, 2021 | 17 | 2021 |
| Development and functional characterization of a versatile radio-/immunotheranostic tool for prostate cancer management C Arndt, R Bergmann, F Striese, K Merkel, D Máthé, LR Loureiro, ... Cancers 14 (8), 1996, 2022 | 11 | 2022 |
| Validation of CD98hc as a therapeutic target for a combination of radiation and immunotherapies in head and neck squamous cell carcinoma AS Köseer, LR Loureiro, J Jureczek, N Mitwasi, KE González Soto, ... Cancers 14 (7), 1677, 2022 | 9 | 2022 |
| Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells HA Saleh, N Mitwasi, M Ullrich, M Kubeil, M Toussaint, W Deuther-Conrad, ... Frontiers in Immunology 14, 1166169, 2023 | 4 | 2023 |
| Presymptomatic Reduction of Individuality in the AppNL-F Knockin Model of Alzheimer’s Disease F Ehret, MS Pelz, AN Senko, KEG Soto, H Liu, G Kempermann Biological Psychiatry 94 (9), 721-731, 2023 | 2 | 2023 |
| FLT3‐directed UniCAR T‐cell therapy of acute myeloid leukaemia JC Peschke, R Bergmann, M Mehnert, KE Gonzalez Soto, LR Loureiro, ... British Journal of Haematology 202 (6), 1137-1150, 2023 | 2 | 2023 |
| A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells A Kegler, L Drewitz, C Arndt, C Daglar, L Rodrigues Loureiro, N Mitwasi, ... Frontiers in Immunology 14, 1204543, 2023 | 2 | 2023 |
| Targeting colorectal cancer cells using AND-gated adaptor RevCAR T-cells KEG Soto, LR Loureiro, T Bartsch, C Arndt, A Kegler, N Mitwasi, L Drewitz, ... Frontiers in Immunology 14, 1302354, 2023 | 1 | 2023 |
| RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma HA Saleh, N Mitwasi, L R. Loureiro, A Kegler, KEG Soto, L Hoffmann, ... Cancer Gene Therapy, 1-12, 2024 | | 2024 |
| FLT3-directed UniCAR T-cell therapy of acute myeloid leukaemia (vol 202, pg 1137, 2023) JC Peschke, R Bergmann, M Mehnert, KE Soto, LR Loureiro, N Mitwasi, ... BRITISH JOURNAL OF HAEMATOLOGY, 2024 | | 2024 |
| DEVELOPMENT OF A CLINICAL SCALE MANUFACTURING PROCESS FOR GENERATING ORGAN-TARGETED REVCAR REGULATORY T-CELLS KL Krishnakumar, A Kegler, JW Li, JM Morales, SS Nirmala, LR Loureiro, ... HUMAN GENE THERAPY 34 (21-22), A10-A11, 2023 | | 2023 |
| DEVELOPMENT OF A NOVEL ACE2 DECOY FOR BOTH SARS-COV-2 VARIANT NEUTRALIZATION AND INFECTED CELL ELIMINATION VIA UNMODIFIED OR CAR MODIFIED IMMUNE CELLS L Drewitz, A Kegler, C Arndt, C Daglar, LR Loureiro, N Mitwasi, C Neuber, ... HUMAN GENE THERAPY 34 (21-22), A34-A34, 2023 | | 2023 |
